Anzeige
Mehr »
Login
Sonntag, 26.01.2025 Börsentäglich über 12.000 News von 683 internationalen Medien
US-Präsident setzt auf die Solana Blockchain! Diese Krypto-Perle profitiert enorm!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
842 Leser
Artikel bewerten:
(2)

American IRA, LLC: American IRA Discusses How Investing in a Private Company in a Self-Directed IRA Works

Finanznachrichten News

CHARLOTTE, NC / ACCESSWIRE / January 30, 2021 / One of the nontraditional retirement assets available to retirement investors through a Self-Directed IRA is that of private company stock. Private company stock affords investors the opportunity to build a lot of growth in a retirement account-and with the tax protections that come with a retirement account, this can be a powerful way to invest wealth efficiently. However, as a recent post at American IRA notes, using a Self-Directed IRA means that the investor is in the driver's seat. And when investing in a private company, the investor makes the calls. That means taking on risk.

The post detailed how investing in a private company with a Self-Directed IRA will work in a practical sense. American IRA routinely posts information about how Self-Directed IRAs work, informing potential investors who are researching alternative ways of investing for retirement. As American IRA often notes, it is a Self-Directed IRA administration firm that does not make specific investing recommendations. However, it does post information on the nontraditional retirement asset classes available to investors who use a Self-Directed IRA.

"Private company investment can be a powerful way to invest," said Jim Hitt, CEO of American IRA. Hitt noted how private company stock does not necessarily correlate to the state of the stock market, which may also give investors some degree of independence. However, this is no guarantee of where investments may head. "As a Self-Directed IRA administration firm, we at American IRA don't make specific investment recommendations. But for investors who invest in private companies and make sound decisions, it can be a unique way to diversify one's assets."

The post digs into the nitty-gritty details on how private company investing works with a Self-Directed IRA administration firm. This includes how the paperwork works. The article likens it to the process of buying stock through a broker-with some obvious differences.

For more information, visit the article at www.AmericanIRA.com. Interested parties may also contact American IRA by dialing 866-7500-IRA.

About:
"American IRA, LLC was established in 2004 by Jim Hitt, CEO in Asheville, NC.

The mission of American IRA is to provide the highest level of customer service in the self-directed retirement industry. Jim Hitt and his team have grown the company to over $400 million in assets under administration by educating the public that their Self-Directed IRA account can invest in a variety of assets such as real estate, private lending, limited liability companies, precious metals, and much more.

As a Self-Directed IRA administrator, they are a neutral third party. They do not make any recommendations to any person or entity associated with investments of any type (including financial representatives, investment promoters or companies, or employees, agents, or representatives associated with these firms). They are not responsible for and are not bound by any statements, representations, warranties, or agreements made by any such person or entity and do not provide any recommendation on the quality, profitability, or reputability of any investment, individual, or company. The term "they" refers to American IRA, located in Asheville and Charlotte, NC and Atlanta, GA."

SOURCE: American IRA, LLC



View source version on accesswire.com:
https://www.accesswire.com/621245/American-IRA-Discusses-How-Investing-in-a-Private-Company-in-a-Self-Directed-IRA-Works

© 2021 ACCESS Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Diesen Artikel auf Deutsch lesen
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.